Gilead Presents Promising Phase 1 Data for Once-Yearly Lenacapavir as HIV Pre-Exposure Prophylaxis

Gilead Sciences, Inc. presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company...

March 12, 2025 | Wednesday | News
Merck ( MSD ) Opens $1 Billion Vaccine Manufacturing Facility in Durham, North Carolina

Merck, known as MSD outside of the United States and Canada, announced  the opening of a new, $1 billion, 225,000-square-foot facility dedicated to va...

March 12, 2025 | Wednesday | News
Doer Bio Completes Phase 2 Enrollment for DR10624 Tri-Agonist in Severe Hypertriglyceridemia

Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and...

March 10, 2025 | Monday | News
Roche Opens Genentech Innovation Center in Boston, Expands Harvard R&D and AI Collaboration

Roche  announced  the launch of the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston which will ...

March 10, 2025 | Monday | News
Johnson & Johnson Reports Promising Phase 3 Data for Icotrokinra in Plaque Psoriasis, Launches Head-to-Head Study

Johnson & Johnson announced new icotrokinra (JNJ-2113) data from its comprehensive Phase 3 clinical program and the start of the first-ever head-t...

March 10, 2025 | Monday | News
ImmunoGenesis Doses First Patient in Phase 1/2 Trial of IMGS-101 Combination Therapy for Advanced Cancers

ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announced the first patient has been dosed in the co...

March 07, 2025 | Friday | News
iTeos Therapeutics Reports Strong 2024 Financial Results and Strategic Update for 2025

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology treatm...

March 07, 2025 | Friday | News
BeiGene Wins FDA Approval for TEVIMBRA® in First-Line Esophageal Cancer Treatment

BeiGene, Ltd.  a global oncology company that intends to change its name to BeOne Medicines Ltd., announced the U.S. Food and Drug Administr...

March 06, 2025 | Thursday | News
GHIT Fund Marks Milestone with First Administration of Arpraziquantel to Preschool Children in Uganda

The Global Health Innovative Technology (GHIT) Fund is announcing a significant milestone: the first administration of arpraziquantel to preschool-aged chi...

March 05, 2025 | Wednesday | News
Myosin Therapeutics Secures Funding to Advance MT-125 for Glioblastoma, MT-110 for Addiction

 Myosin Therapeutics, Inc., a biotechnology company developing novel therapies for cancer and neurological disorders, has closed its second seed fundi...

March 04, 2025 | Tuesday | News
CStone Begins Phase I Trial of CS2009 Trispecific Antibody for Solid Tumors

CStone Pharmaceuticals, an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, announced that&nbs...

March 04, 2025 | Tuesday | News
QIAGEN Sues bioMérieux in German Patent Court to Protect QuantiFERON Technology

QIAGEN files lawsuit against bioMérieux with German Unified Patent Court to protect key innovations in its QuantiFERON technology Qua...

March 03, 2025 | Monday | News
SK bioscience Secures PAHO Contract Extension to Supply SKYVaricella® to Latin America Through 2027

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that the compan...

February 28, 2025 | Friday | News
Rapid Micro Biosystems Partners with MilliporeSigma for Global Distribution and Collaboration on Growth Direct Systems

Rapid Micro Biosystems, Inc. (the “Company” or “Rapid Micro”), an innovative life sciences technology company providing mission cri...

February 28, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close